Matches in Wikidata for { <http://www.wikidata.org/entity/Q63344298> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63344298 description "article scientifique publié en 2018" @default.
- Q63344298 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q63344298 description "wetenschappelijk artikel" @default.
- Q63344298 description "наукова стаття, опублікована в січні 2018" @default.
- Q63344298 name "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 name "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 type Item @default.
- Q63344298 label "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 label "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 prefLabel "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 prefLabel "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 P1433 Q63344298-A450F8DF-850B-4CE2-956C-BB45FDEDA952 @default.
- Q63344298 P1476 Q63344298-8594FF67-3227-4701-9D91-953EE634B5F3 @default.
- Q63344298 P2093 Q63344298-09BA469C-9FFA-46F4-A536-5483AEFFCDCF @default.
- Q63344298 P2093 Q63344298-2BBF7E62-8ACF-43AF-A6A7-7E46A64BA807 @default.
- Q63344298 P2093 Q63344298-74307692-2E22-4568-ACBB-960230F48FCB @default.
- Q63344298 P2093 Q63344298-77644146-5D39-46F6-9201-8A06F958FD6C @default.
- Q63344298 P2093 Q63344298-947A0686-3211-491F-829F-F64404D62D0D @default.
- Q63344298 P2093 Q63344298-94A18D5F-CF89-4CE9-A2F9-235099791E48 @default.
- Q63344298 P2093 Q63344298-A4929651-FDF3-47DC-9CA3-99AB766CFD6D @default.
- Q63344298 P304 Q63344298-D2012876-E055-4E09-9321-AA415149EC8F @default.
- Q63344298 P31 Q63344298-859D624A-C6FB-4C1A-A9FF-2A497AAFCE57 @default.
- Q63344298 P356 Q63344298-AEC1EF97-51F9-4E4E-A55D-82A4BEEA8A15 @default.
- Q63344298 P478 Q63344298-A30183A6-7FE4-4B3E-985D-61EBD79EB15E @default.
- Q63344298 P577 Q63344298-FD162335-8E17-46B2-95DC-B0030A54AEA4 @default.
- Q63344298 P921 Q63344298-95B3C83E-DBF3-4FF9-8963-B58279DCD4D2 @default.
- Q63344298 P356 J.JFF.2017.11.007 @default.
- Q63344298 P1433 Q15817007 @default.
- Q63344298 P1476 "Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway" @default.
- Q63344298 P2093 "Carmen Piñol" @default.
- Q63344298 P2093 "Laura Rubió" @default.
- Q63344298 P2093 "Maria-Carmen López de las Hazas" @default.
- Q63344298 P2093 "Maria-José Motilva" @default.
- Q63344298 P2093 "Rosa Solà" @default.
- Q63344298 P2093 "Sara Fernandez-Castillejo" @default.
- Q63344298 P2093 "Úrsula Catalán" @default.
- Q63344298 P304 "280-291" @default.
- Q63344298 P31 Q13442814 @default.
- Q63344298 P356 "10.1016/J.JFF.2017.11.007" @default.
- Q63344298 P478 "40" @default.
- Q63344298 P577 "2018-01-01T00:00:00Z" @default.
- Q63344298 P921 Q12252367 @default.